We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.65%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$59.5B
AUM Growth
+$3.71B
Cap. Flow
+$2.71B
Cap. Flow %
4.55%
Top 10 Hldgs %
19.97%
Holding
3,755
New
295
Increased
1,969
Reduced
1,191
Closed
173

Sector Composition

Rank Sector Weight
1 Technology 10.24%
2 Financials 9.05%
3 Healthcare 7.82%
4 Industrials 6.6%
5 Energy 5.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKK
3251
DELISTED
Blackrock Municipal 2020 Term Trust
BKK
$194K ﹤0.01%
12,893
-2,970
-19% -$44.9K
CRWS icon
3252
Crown Crafts
CRWS
$32.3M
$193K ﹤0.01%
33,800
NXJ
3253
DELISTED
Nuveen New Jersey Quality Municipal Income Fund
NXJ
$192K ﹤0.01%
14,731
-4,096
-22% -$53.3K
VSTM icon
3254
Verastem
VSTM
$610M
$192K ﹤0.01%
2,324
-133
-5% -$8.14K
CVX icon
3255
CALL
Chevron
CVX
$366B
$190K ﹤0.01%
78,900
+27,600
+54% +$3.43M
CVE icon
3256
Cenovus Energy
CVE
$52.1B
$189K ﹤0.01%
18,166
-3,509
-16% -$35.4K
MLP icon
3257
Maui Land & Pineapple Co
MLP
$344M
$189K ﹤0.01%
+16,895
New +$192K
SMB icon
3258
VanEck Short Muni ETF
SMB
$314M
$189K ﹤0.01%
10,941
+172
+2% +$2.96K
EMF
3259
Templeton Emerging Markets Fund
EMF
$326M
$188K ﹤0.01%
12,746
-1,946
-13% -$30.2K
WNEB icon
3260
Western New England Bancorp
WNEB
$275M
$188K ﹤0.01%
17,055
JRS icon
3261
Nuveen Real Estate Income Fund
JRS
$246M
$187K ﹤0.01%
18,705
+362
+2% +$3.54K
PFX icon
3262
PhenixFIN
PFX
$90M
$187K ﹤0.01%
+2,692
New +$205K
ADAP
3263
DELISTED
Adaptimmune Therapeutics
ADAP
$185K ﹤0.01%
15,596
-9,544
-38% -$119K
CEV
3264
Eaton Vance California Municipal Income Trust
CEV
$73.6M
$185K ﹤0.01%
16,177
+2,609
+19% +$29.8K
SGRY icon
3265
Surgery Partners
SGRY
$2.03B
$185K ﹤0.01%
+12,445
New +$209K
RWT
3266
Redwood Trust
RWT
$594M
$184K ﹤0.01%
11,165
-400
-3% -$6.42K
PZN
3267
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$184K ﹤0.01%
20,000
GUT
3268
Gabelli Utility Trust
GUT
$559M
$183K ﹤0.01%
31,810
-1,822
-5% -$10.5K
PCM
3269
PCM Fund
PCM
$70.1M
$181K ﹤0.01%
15,774
NTBL
3270
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$181K ﹤0.01%
2,347
FULT icon
3271
Fulton Financial
FULT
$4.64B
$180K ﹤0.01%
+10,892
New +$189K
FLWS icon
3272
1-800-Flowers.com
FLWS
$258M
$178K ﹤0.01%
14,200
VNTR
3273
DELISTED
Venator Materials PLC
VNTR
$178K ﹤0.01%
10,884
-10,435
-49% -$186K
ACHN
3274
DELISTED
Achillion Pharmaceuticals
ACHN
$178K ﹤0.01%
63,050
+200
+0.3% +$681
MOBL
3275
DELISTED
MobileIron, Inc.
MOBL
$178K ﹤0.01%
40,034
-500
-1% -$2.28K

Similar funds

Raymond James & Associates's Q2 2018 Portfolio in Review

As of Q2 2018, Raymond James & Associates held 3,755 positions worth $59.5B, up 6.7% from $55.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raymond James & Associates deployed $2.71B of net new capital in Q2 2018, opening 295 new positions and adding to 1,969 existing holdings. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 727,426 shares worth $45.6M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 10% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $97.9M trimmed.

  • Raymond James & Associates's largest Q2 2018 buy was Vanguard Intermediate-Term Treasury ETF: 727,426 shares worth $45.6M.
  • Raymond James & Associates added most to iShares Core MSCI EAFE ETF in Q2 2018, an estimated $167M increase.
  • Raymond James & Associates's biggest Q2 2018 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $97.9M.
  • Raymond James & Associates fully exited Time Warner Inc in Q2 2018, selling an estimated $118M.
  • Raymond James & Associates's ten largest holdings make up 20% of its $59.5B portfolio in Q2 2018.
  • Raymond James & Associates opened 295 new positions and closed 173 in Q2 2018.
  • Raymond James & Associates's portfolio value rose 6.7% quarter-over-quarter to $59.5B.

Based on Raymond James & Associates's 13F filing for Q2 2018, filed 14 Aug 2018.